A ventilation/perfusion lung scan (V/Q scan) is a reliable alternative to CT angiograms in diagnosing pulmonary embolisms, especially in young women. The study found that V/Q scans can exclude pulmonary embolism with low probability clinical assessment, reducing radiation exposure and breast cancer risk.
The Society of Nuclear Medicine and Molecular Imaging has revised its nuclear medicine technologist's scope of practice, reflecting changes in technology and molecular imaging. The updated document includes procedures such as CT scans and administering contrast.
Researchers found that antidepressant medicines normalized decreased brain blood flow in patients with depression, while electroconvulsive therapy was associated with additional decreases. Objective imaging evaluations may support subjective clinical decisions in treating depression.
SNM presented special recognition awards to 7 lawmakers who support the profession. The organization highlighted their dedication to patient care and safety through initiatives like the CARE Act. SNM's annual meeting will be held June 2-6 at the Washington Convention Center.
The Society of Nuclear Medicine and Molecular Imaging has developed a broad definition for molecular imaging, capturing the essence of an evolving and multidisciplinary field. The definition provides a concise explanation of the meaning of molecular imaging, including techniques such as radiotracer imaging, MRI, and optical imaging.
Scientists have discovered a statistical relationship between brain levels of the enzyme monoamine oxidase A (MAO) A and aggressive personality in healthy non-violent volunteers. The study found that higher MAO A activity was associated with less aggressive behavior, while lower MAO A activity was linked to more aggressive tendencies.
A new study demonstrates the value of PET/CT in diagnosing and monitoring Crohn's disease, offering a non-invasive alternative to invasive endoscopy. The scan can accurately identify active disease and detect severe lesions, reducing the need for costly and side-effect-ridden treatments.
Researchers studied hypothyroidism's impact on brain metabolism and found a correlation between the condition and decreased metabolic activity in specific brain regions. These changes remain detectable even after thyroid hormone replacement therapy, suggesting a complex relationship between physical health and mental well-being.
Researchers at Rambam Health Care Campus in Israel have found that PET/CT imaging can accurately diagnose and localize vascular graft-related infections. The study shows promise as a single-step, noninvasive technique for complex patients, potentially sparing unnecessary high-risk operations.
Researchers unveiled the world's first simultaneous PET/MR images of the human brain, offering unprecedented imaging capabilities for neurological studies. The technology has the potential to revolutionize the assessment of Alzheimer's, Parkinson's, epilepsy, depression, and schizophrenia.
A study published at SNM's 54th Annual Meeting found that PET/CT imaging detected more sites of disease and identified women whose disease was likely to progress. The technique influenced treatment decisions in 59% of women with recurrent ovarian cancer, improving management outcomes.
Researchers from University of Pennsylvania and Philips team demonstrate improved image quality and shorter patient scan times with advanced molecular imaging technology. The study, released at SNM's 54th Annual Meeting, shows that TOF/PET imaging can achieve better quality images in less time, benefiting patients and doctors.
Beta-amyloid accumulation is linked to brain dysfunction even in normal elderly individuals, according to a study. Researchers used PIB PET scans to detect early pathological changes of Alzheimer's disease and demonstrated its potential for identifying those in need of treatment.
Researchers found that percutaneous ethanol injection (PEI) significantly reduces tumor volume and alleviates symptoms in patients with radioiodine-ineffective bone metastasis from thyroid cancer. PEI's effectiveness was also linked to improved quality of life for selected patients.
Researchers developed a novel imaging technique combining CT and PET scans to detect 'high-risk' plaque that causes heart attacks and strokes. The approach provides detailed information about the size of plaque, inflammation, and potential risks, offering new insights into atherosclerosis.
Researchers developed a 3D fusion technique combining CT angiography and nuclear imaging scans to improve the accuracy of diagnosing coronary artery disease. This technology significantly enhances diagnosis and could be used in the future with molecular imaging agents to detect and guide treatment.
Michael R. Zalutsky received the award for his significant contributions to medical science, especially in using molecular targeting to combat cancer. His research has had a substantial impact on therapeutic nuclear medicine and its applications.
Early metabolic imaging with PET accurately identifies patients responding to chemotherapy for esophageal cancer, noting a remarkably favorable outcome for metabolic responders. This study supports the use of PET-response-guided treatment to tailor multimodality therapy based on tumor biology.
Researchers developed a new imaging technique that combines functional and anatomical imaging to diagnose coronary artery disease more accurately. This 'synergy' approach uses software to integrate data from SPECT and CT angiography scans, providing clearer pictures of the heart muscle and coronary arteries.
Using metabolic imaging, UCLA researchers found that FLT-PET is a powerful predictor of treatment response and outcome in brain tumor patients. The study showed that FLT-PET imaging was predictive of patients' overall survival, with those who responded to drug treatment living three times as long as those who did not.
R. Edward Coleman received the award for his contributions to molecular imaging and nuclear medicine practice, particularly in advancing positron emission tomography (PET) for breast cancer, Alzheimer's, and brain tumors. His research has had a significant impact on medicine, and he is recognized as one of the best doctors in America.
Researchers found that FDG-PET imaging can identify patients who respond to chemotherapy, allowing for early termination of futile treatment. This improves patient care by providing an alternative approach, such as stopping chemotherapy or switching to a more adequate therapeutic option.
A new nuclear medicine technique using annexin A5 imaging may help identify individuals at risk of developing heart failure by detecting programmed cell loss in the heart muscle. This could lead to earlier intervention and improved treatment options, as cell death is a key factor in worsening left ventricular events.
Scientists have developed a method for delivering thermal ablation directly to tumor cells using nanotechnology and molecular imaging. By attaching magnetic iron-containing bioprobes to cancer cells and heating them with an alternating magnetic field, researchers were able to weaken and destroy malignant cells without damaging nearby h...
Researchers found that SPECT/CT imaging enhances sentinel node identification in overweight patients with breast cancer. The study suggests this improved technique can reduce the need for unnecessary surgery and improve treatment outcomes.
Researchers have developed a promising radiotracer, FACBC, to improve prostate cancer diagnosis and staging. The tracer shows high accumulation in cancer cells and potential for overcoming traditional PET tracers' drawbacks.
The supplement examines the role of 18F-FDG PET/CT imaging in cancer diagnosis, treatment planning, and monitoring. It provides guidelines and algorithms for the use of PET/CT in evaluating and managing head and neck cancer and thyroid cancer.
The Society of Nuclear Medicine and Molecular Imaging identifies the most promising lab-based discoveries to translate into routine patient benefit. Experts emphasize the need for shared standards, innovative approaches, and cooperation among sectors to accelerate molecular imaging's translation.
A new study published in the Journal of Nuclear Medicine found that young smokers who quit smoking can normalize abnormal coronary artery function within a month. The PET imaging study examined the effects of smoking cessation on coronary endothelial dysfunction in healthy young male adults.
Advances in PET technology enable early disease detection and personalized medicine, potentially leading to annual screenings for common diseases. Doctors will use PET's molecular imaging ability to visualize precise molecular changes, informing treatment and prevention strategies.
The Society of Nuclear Medicine and Molecular Imaging emphasizes the beneficial aspects of nuclear medicine, a highly effective diagnostic and treatment method. Every major hospital has a nuclear medicine department, performing over 19 million procedures annually, increasing by 15% from four years ago.
A recent study published in the Journal of Nuclear Medicine reveals that diabetes mellitus significantly slows nerve recovery after a heart transplant. This finding highlights the importance of understanding nervous system abnormalities to guide therapeutic efforts aimed at reducing cardiac risk for patients with diabetes.
Researchers identified an accurate method to detect coronary artery disease risk in obese individuals using stress myocardial perfusion imaging. The test can help physicians plan management strategies for patients with 'silent' disease, reducing the risk of angina, heart attack, and death.
At SNM's 53rd Annual Meeting, nearly 2,000 scientific and technologist abstracts were presented on various topics including cardiology, neurology, oncology, pediatrics, infectious disease, and more. The Society of Nuclear Medicine and Molecular Imaging also recognized individuals with named awards, lectures, and honors.
Stanford University researchers developed a 3D PET/CT imaging technique that provides a visual navigation of organs, allowing for better detection and characterization of cancer. The technology has potential for presurgical visualization, guiding biopsies and identifying tumor 'hot spots', enabling more precise diagnosis and treatment.
The publication of consensus recommendations for FDG PET usage is expected to reduce variability in clinical trials, leading to shorter trials and improved treatment outcomes. The guidelines provide a valuable reference for incorporating PET into clinical trials and promoting drug development.
Researchers present a new non-invasive cardiac imaging technology that enables accurate evaluation of cardiac blood vessel narrowing and blood supply to the heart muscles in a single imaging session. The technology combines SPECT perfusion imaging with CT coronary angiography, providing more accurate information than stand-alone tests.
Researchers at Johns Hopkins Medicine have developed a new PET radioligand, [11C]JHU75528, which allows for noninvasive visualization of central cannabinoid CB1 receptors in the human and animal brain. This breakthrough could lead to the development of new medications for treating obesity and drug dependence.
Researchers used FLT PET to monitor treatment response in DLBCL patients treated with R-CHOP chemotherapy. Treatment led to temporary increases in FLT uptake, indicating increased DNA synthesis and tumor cell proliferation. This suggests that FLT PET may be a sensitive tool for differentiating non-responding tumors.
The D-SPECT camera reduces image acquisition times by an order of magnitude, provides better image quality, and enables simultaneous multi-isotope imaging for more versatile diagnostics. This technology also offers personalized diagnostics taking into account patient-specific physical information.
Daniel Guarasci, a clinical assistant professor at State University of New York at Buffalo, has been honored with the SNMTS Outstanding Educator Award. He translates complex information into understandable language for students, positively influencing nuclear medicine technology students.
Researchers found a link between increased serotonin receptors and body weight in overweight individuals. The discovery suggests that serotonin receptor manipulation could be a potential target for treating obesity.
Alexander Gottschalk, a Michigan State University professor, received the 2006 Benedict Cassen Prize for his groundbreaking research in nuclear medicine. He made significant contributions to the field, including dynamic camera studies of the brain and heart using technetium-99m.
Researchers develop IMPY tracer to visualize abnormal protein in Alzheimer's and prion diseases, providing new directions for future research. The tracer may also aid in early diagnosis of Alzheimer's with single photon emission computed tomography (SPECT) imaging.
Researchers have developed a technology that can reduce imaging time for cardiac stress/rest tests by 50% without compromising image quality. This innovation allows for increased patient comfort and improved throughput in nuclear medicine departments, enabling more patients to be scanned without additional floor space or equipment.
Researchers at UCLA have developed a new method to detect Alzheimer's disease progression using FDDNP PET. The study shows that the worsening of memory and cognitive functions is correlated with increased 18F-FDDNP brain binding, providing valuable information for diagnosis and monitoring therapeutic interventions.
Researchers found that FDG PET scans can accurately diagnose fevers of unknown origin in half of cases, eliminating the need for further tests. The study suggests that FDG PET offers an effective tool for early diagnosis, risk stratification, and treatment, reducing hospital stays.
Researchers have found that an ADHD medication 'harmonizes' with the body's dopamine system, improving attention and focus in individuals. The study, presented at a medical conference, provides direct evidence of the drug's beneficial effect, which was previously speculative.
Researchers have developed a new treatment protocol combining radionuclide therapy and chemotherapy that induces regression of prostate cancer in patients with metastatic disease. The combination regimen has been shown to alleviate bone pain and produce clinical benefit, including prolonged survival and reduced PSA levels.
Researchers used FDG-PET imaging to diagnose osteomyelitis, achieving a 93% accuracy rate. The study's findings support the use of FDG PET as a diagnostic tool for chronic osteomyelitis.